Market Tracker

11/21 6:05pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

35.94
Data as of Nov 21
 -0.15 / -0.42%
Today’s Change
27.51
Today|||52-Week Range
39.95
+23.08%
Year-to-Date

Today’s Trading

Previous close36.09
Today’s open36.70
Day’s range35.80 - 36.84
Volume465,410
Average volume (3 months)710,772
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)+14.66%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio64.2
Price/Sales3.49
Price/Book3.34

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.03+0.04%
NBIXNeurocrine Bioscienc...+0.36+1.94%
HZNPHorizon Pharma PLC-0.50-4.02%
RAREUltragenyx Pharmaceu...-0.58-1.30%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts